Skip to main content
SpringerLink
Log in

Mammographic Density as a Potential Surrogate Marker for Breast Cancer

  • Chapter
  • First Online:
Breast Cancer Epidemiology

Abstract

Despite extensive research, the causes of most cases of breast cancer remain unknown, although there is strong evidence that risk of the disease is influenced by both genetic and environmental factors (Veronesi et al. 2005). We consider here the potential role of mammographic density as a surrogate marker in research on the etiology and prevention of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aiello EJ, Tworoger SS, Yasui Y et al (2005) Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev 14(6):1411–1417

    Article  CAS  PubMed  Google Scholar 

  • American College of Radiology (ACR) (1998) Breast imaging reporting and data system (BI-RADS). American College of Radiology [Third]. American College of Radiology, Reston

    Google Scholar 

  • Bartow SA, Mettler FA Jr, Black WC III (1997) Correlations between radiographic patterns and morphology of the female breast. Rad Patterns Morph 13:263–275

    Google Scholar 

  • Beral V, Bull D, Doll R, Peto R, Reeves G (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. Lancet 358(9291):1389–1399

    Article  Google Scholar 

  • Bérubé S, Diorio C, Verhoek-Oftedahl W, Brisson J, Vitamin D (2004) calcium, and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 13(9):1466–1472

    PubMed  Google Scholar 

  • Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M (2002) A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 11(10 Pt 1):1048–1053

    PubMed  Google Scholar 

  • Boyd NF, Dite GS, Stone J et al (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347(12):886–894

    Article  PubMed  Google Scholar 

  • Boyd NF, Greenberg C, Lockwood G et al (1997) Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group. J Natl Cancer Inst 89(7):488–496

    Article  CAS  PubMed  Google Scholar 

  • Boyd NF, Guo H, Martin LJ et al (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356(3):227–236

    Article  CAS  PubMed  Google Scholar 

  • Boyd NF, Lockwood GA, Byng J, Tritchler DL, Yaffe M (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7(12):1133–1144

    CAS  PubMed  Google Scholar 

  • Boyd NF, Lockwood GA, Byng JW, Yaffe MJ, Tritchler DL (1998) The relationship of anthropometric measures to radiological features of the breast in premenopausal women. Br J Cancer 78(9):1233–1238

    CAS  PubMed  Google Scholar 

  • Boyd NF, Martin LJ, Li Q et al (2006) Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15(5):961–966

    Article  CAS  PubMed  Google Scholar 

  • Boyd NF, Martin LJ, Sun L et al (2006) Body size, mammographic density and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15(11):2086–2092

    Article  PubMed  Google Scholar 

  • Boyd NF, Rommens JM, Vogt K et al (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet 6(10):798–808

    Article  Google Scholar 

  • Boyd NF, Stone J, Martin LJ et al (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87(8):876–882

    Article  CAS  PubMed  Google Scholar 

  • Bremnes Y, Ursin G, Bjurstam N, Rinaldi S, Kaaks R, Gram IT (2007) Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women. Int J Cancer 121(11):2506–2511

    Article  CAS  PubMed  Google Scholar 

  • Brisson J, Brisson B, Coté G, Maunsell E, Bérubé S, Robert J (2000) Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 9(9):911–915

    CAS  PubMed  Google Scholar 

  • Byrne C, Schairer C, Wolfe J et al (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87(21):1622–1629

    Article  CAS  PubMed  Google Scholar 

  • Carlson CS, Eberle MA, Kruglyak L, Nickerson DA (2004) Mapping complex disease loci in whole-genome association studies. Nature 429(6990):446–452

    Article  CAS  PubMed  Google Scholar 

  • Chlebowski RT, Hendrix SL, Langer R et al (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women’s Health Initiative Randomized Trial. JAMA 289(24):3243–3253

    Article  CAS  PubMed  Google Scholar 

  • Cuzick J, Warwick J, Pinney E, Warren RML, Duffy SW (2004) Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96(8):621–628

    Article  CAS  PubMed  Google Scholar 

  • Eilertsen AL, Karssemeijer N, Skaane P, Qvigstad E, Sandset PM (2008) Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method. BJOG May;115(6):773–779

    Article  CAS  PubMed  Google Scholar 

  • Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 90(18):1371–1388

    Google Scholar 

  • Freedman LS, Graubard BI (1992) Statistical validation of intermediate endpoints for chronic diseases. Stat Med 11(2):167–178

    Article  CAS  PubMed  Google Scholar 

  • Freedman M, San Martin J, O’Gorman J et al (2001) Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. J Natl Cancer Inst 93(1):51–56

    Article  CAS  PubMed  Google Scholar 

  • Gertig DM, Stillman IE, Byrne C et al (1999) Association of age and reproductive factors with benign breast tissue composition. Cancer Epidemiol Biomarkers Prev 8(10):873–879

    CAS  PubMed  Google Scholar 

  • Gram IT, Funkhouser E, Tabar L (1997) The Tabar classification of mammographic parenchymal patterns. Eur J Radiol 24(2):131–136

    Article  CAS  PubMed  Google Scholar 

  • Greendale GA, Palla SL, Ursin G et al (2005) The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Am J Epidemiol 162(9):826–834

    Article  PubMed  Google Scholar 

  • Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G (2003) Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95(1):30–37

    Article  CAS  PubMed  Google Scholar 

  • Hankinson SE, Willett WC, Michaud DS et al (1999) Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 91(7):629–634

    Article  CAS  PubMed  Google Scholar 

  • Hofling M, Lundstrom E, Azavedo E, Svane G, Hirschberg AL, von Schoultz B (2007) Testosterone addition during menopausal hormone therapy: effects on mammographic breast density. Climacteric 10(2):155–163

    Article  CAS  PubMed  Google Scholar 

  • Hunter DJ, Willett WC (1993) Diet, body size, and breast cancer. Epidemiol Rev 15(1):110–132

    CAS  PubMed  Google Scholar 

  • Johansson H, Gandini S, Bonanni B, Marieet F, Guerrieri-Gonzaga A, Serrano D et al (2008) Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. Breast Cancer Res Treat 108:57–67

    Article  CAS  PubMed  Google Scholar 

  • Kelsey JL, Gammon MD, John ES (1993) Reproductive factors and breast cancer. Epidemiol Rev 15(1):36–47

    CAS  PubMed  Google Scholar 

  • Kerlikowske K, Ichikawa L, Miglioretti DL et al (2007) Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 99(5):386–395

    Article  PubMed  Google Scholar 

  • Key TJ, Appleby PN, Reeves GK et al (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95(16):1218–1226

    Article  CAS  PubMed  Google Scholar 

  • Li T, Sun L, Miller N et al (2005) The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 14(2):343–349

    Article  PubMed  Google Scholar 

  • Martin LJ, Boyd N (2008) Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 10(1):1–14

    Article  Google Scholar 

  • Maskarinec G, Meng L, Ursin G (2001) Ethnic differences in mammographic densities. Int J Epidemiol 30(5):959–965

    Article  CAS  PubMed  Google Scholar 

  • Maskarinec G, Pagano I, Lurie G, Kolonel LN (2006) A longitudinal investigation of mammographic density: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 15(4):732–739

    Article  PubMed  Google Scholar 

  • McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(6):1159–1169

    Article  PubMed  Google Scholar 

  • McTiernan A, Martin DF, Peck JD et al (2005) Estrogen-plus-progestin use and mammographic density in postmenopausal women: women’s health initiative randomized trial. J Natl Cancer Inst 97(18):1366–1376

    Article  CAS  PubMed  Google Scholar 

  • Muir C, Waterhouse T, Mack J, Powell S, Whelan S (1992) Cancer incidence in five continents. Volume V1 ed. IARC Scientific Publication, Lyon

    Google Scholar 

  • Noh JJ, Maskarinec G, Pagano I, Cheung LW, Stanczyk FZ (2006) Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast 15(1):20–28

    Article  PubMed  Google Scholar 

  • Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG (1983) “Hormonal” risk factors, “breast tissue age” and the age-incidence of breast cancer. Nature 303(5920):767–770

    Article  CAS  PubMed  Google Scholar 

  • Pisano ED, Gatsonis C, Hendrick E et al (2005) Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353(17):1773–1783

    Article  CAS  PubMed  Google Scholar 

  • Prentice RL (1988) Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 8(4):431–440

    Article  Google Scholar 

  • Renehan AG, Harvie M, Howell A (2006) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer 13(2):273–278

    Article  CAS  PubMed  Google Scholar 

  • Rosner B, Colditz G (1996) Nurses’ health study: log-incidence mathematical model of breast cancer incidence. J Natl Cancer Inst 88(6):359–364

    Article  CAS  PubMed  Google Scholar 

  • Schatzkin A, Gail M (2002) The promise and peril of surrogate end points in cancer research. Nat Rev 2(1):19–27

    CAS  Google Scholar 

  • Spicer DV, Ursin G, Parisky YR et al (1994) Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 86(6):431–436

    Article  CAS  PubMed  Google Scholar 

  • Tamimi RM, Byrne C, Colditz GA, Hankinson SE (2007) Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99(15):1178–1187

    Article  CAS  PubMed  Google Scholar 

  • Tamimi RM, Hankinson SE, Colditz GA, Byrne C (2005) Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev 14(11 Pt 1):2641–2647

    Article  CAS  PubMed  Google Scholar 

  • Tworoger SS, Eliassen AH, Sluss P, Hankinson SE (2007) A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol 25(12):1482–1488

    Article  CAS  PubMed  Google Scholar 

  • Ursin G, Wu AH, Bernstein L et al (2003) Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 12(4):332–338

    PubMed  Google Scholar 

  • Vachon CM, Kuni CC, Anderson K (2000) Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 11(7):653–662

    Article  CAS  PubMed  Google Scholar 

  • Vachon CM, Ingle JN, Suman VJ, Scott CG, Gottardt H, Olson JE, Goss PE (2007) Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen. Breast Apr;16(2):204–210

    Article  CAS  PubMed  Google Scholar 

  • Vachon CM, Pankratz VS, Scott CG et al (2007) Longitudinal trends in mammographic percent density and breast cancer risk. Cancer Epidemiol Biomarkers Prev 16(5):921–928

    Article  PubMed  Google Scholar 

  • Verheus M, Peeters PHM, van Noord PAH, van der Schouw YT, Grobbee DE, van Gils CH (2007) No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort. Breast Cancer Res 9(4):R53

    Article  PubMed  Google Scholar 

  • Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G (2005) Breast cancer. Lancet 365(9472):1727–1741

    Article  PubMed  Google Scholar 

  • Vogel VG, Costantino JP, Wickerham DL et al (2006) Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295(23):2727–2741

    Article  CAS  PubMed  Google Scholar 

  • Warren R, Skinner J, Sala E et al (2006) Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women. Cancer Epidemiol Biomarkers Prev 15(8):1502–1508

    Article  CAS  PubMed  Google Scholar 

  • Wolfe JN (1976) Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol 126(6):1130–1137

    CAS  PubMed  Google Scholar 

  • Wolfe JN (1976) Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 37(5):2486–2492

    Article  CAS  PubMed  Google Scholar 

  • Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K (2005) Mammographic breast density and family history of breast cancer. J Natl Cancer Inst 95(7):556–558

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, ON, Canada

    Norman F Boyd, Lisa J Martin & Salomon Minkin

Authors
  1. Norman F Boyd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lisa J Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Salomon Minkin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Norman F Boyd .

Editor information

Editors and Affiliations

  1. Fairview Ave. N., 1100, Seattle, 98109, U.S.A.

    Christopher Li

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Boyd, N.F., Martin, L.J., Minkin, S. (2010). Mammographic Density as a Potential Surrogate Marker for Breast Cancer. In: Li, C. (eds) Breast Cancer Epidemiology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0685-4_15

Download citation

Publish with us

Policies and ethics

Search

Navigation